VTAMA® (tapinarof) cream, 1% as a Novel Topical Therapy for Adult Plaque Psoriasis
This promotional activity is provided by Dermavant and is not providing any continuing education contact hours. The content of the Product Theater and opinions expressed by presenters are those of the sponsor and/or presenters and not of the Dermatology Nurses’ Association. Speakers present on behalf of the supporting company and are required to present information in compliance with FDA requirements for communications about its medicines.
Room: 200/201/202